Hevolution Foundation

Name

Hevolution Foundation

Legal name

Hevolution Foundation

Website

https://hevolution.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Philanthropic Research Funding

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industry

Research & Science Grantmaking Foundations (BPAGAKAI)

Keywords

• Biomedical research funding
• Geroscience research grants
• Healthspan science investments
• Aging therapeutics funding
• Longevity biotech grants

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Philanthropic grants and early-stage investments: Hevolution Foundation operates as a non-profit organization that provides grants and early-stage investments to incentivize independent research and entrepreneurship in healthspan science. The foundation funds aging biology research, geroscience, and clinical trials, reinvesting all returns into the field rather than extracting profits.

Distribution channels1 record

Marketing channels6 records

Core offering

Hevolution Foundation is a non-profit organization that provides philanthropic grants and early-stage investments to fund aging biology, geroscience, and healthspan research worldwide. The foundation supports academic researchers, postdoctoral fellows, and early-stage biotech companies developing therapeutics that target the root causes of aging, reinvesting any returns back into the field rather than extracting profits.

Product overview

Hevolution Foundation is a global non-profit organization (not a product company) that provides philanthropic grants and early-stage investments to advance healthspan science. The foundation's offerings include: research grant programs (such as HF-GRO, HF-AGE, HF-PTG, HF-GLA, and Saudi Arabia-specific programs) supporting scientists working on aging biology and geroscience; investment in early-stage biotech companies developing therapies targeting root causes of aging; the Global Healthspan Summit (an annual convening of scientists, researchers, policymakers, investors, and biotech entrepreneurs); and the Global Healthspan Report (an annual publication presenting evidence on aging as a manageable process). These offerings work together to incentivize independent research, build the geroscience ecosystem, and drive the field from basic biology through clinical translation.

Differentiator

Problem solved

Functional benefit

Brands

• Global Healthspan Summit: A global convening event organized by Hevolution Foundation to advance healthspan science, bringing together scientists, researchers, policymakers, investors, and biotech entrepreneurs.

Products and services

• HF-GRO Program
• HF-AGE Program
• HF-PTG Program
• HF-GLA Program
• Saudi Arabia Postdoctoral Fellowships
• Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
• Early-Stage Biotech Investments

Quantifiable outcome

• Reducing period of poor health by just 12 months could generate trillions of dollars annually through higher productivity and lower healthcare costs
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core and minor.

• XPRIZE FoundationcoreStrategic or Co-development Partner · 1 January 2021Partnership on the $101 million XPRIZE Healthspan competition to drive breakthroughs in healthy aging. Hevolution co-founded this initiative to accelerate the field of geroscience and incentivize global innovation in healthspan extension.
• Impetus GrantsminorStrategic or Co-development PartnerStrategic partnership with Impetus Grants as part of Hevolution's global partnerships to accelerate impact, build capacity, acquire knowledge, and increase awareness in healthspan science.
• AFAR (American Federation for Aging Research)coreStrategic or Co-development PartnerCo-development of Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research, providing $375,000 awards over 3 years to junior investigators in Canada and the United States. Also jointly manages the Hevolution Foundation Scientific Conferences Fund.
• VandriaminorStrategic or Co-development PartnerInvestment in Lausanne-based Swiss biotech company Vandria as part of Hevolution's portfolio of companies advancing healthspan science.
• Saudi Arabia National Biotechnology StrategycoreStrategic or Co-development PartnerAlignment with Saudi Arabia's National Biotechnology Strategy which aims to contribute over $34 billion to non-oil GDP by 2040, positioning the Kingdom as a leader in geroscience research.
• National Institutes of Health (NIH)minorStrategic or Co-development PartnerHevolution's HF-AGE program funds projects that were deemed meritorious in NIH peer review but not funded by the National Institute on Aging (NIA) in fiscal year 2023.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• SENS Research Foundation: SENS is a nonprofit foundation funding research into the biological drivers of aging and age-related disease. It overlaps directly with Hevolution's mission of advancing geroscience research and serves a similar investigator base.
• Longevity Science Foundation: A nonprofit that funds research and projects aimed at extending healthy human longevity, including through grants and prizes. It is a direct peer in the healthspan philanthropy category, with comparable grantmaking and ecosystem-building activity.
• AFAR (American Federation for Aging Research): AFAR is a US-based nonprofit that funds aging biology and geroscience research through grants and investigator awards — the closest functional peer to Hevolution. It is also an active co-development partner on the Hevolution/AFAR New Investigator Awards and the Scientific Conferences Fund.

Broad incumbents

• Altos Labs: A well-capitalized private biotechnology company focused on cellular rejuvenation programming to treat aging and age-related diseases. Comparable as a deep-pocketed private longevity player, but operating as a commercial entity rather than a grantmaking foundation.
• Howard Hughes Medical Institute: A large biomedical research philanthropy funding scientists and institutes across the life sciences. Comparable in scale and operating model as a major nonprofit research funder with long investment horizons.
• Wellcome Leap: A nonprofit program funded by the Wellcome Trust that makes large, milestone-driven grants in human health, including aging-related programs. Comparable as a well-capitalized philanthropic health-research funder with global ambitions.
• Calico Life Sciences: Alphabet-backed R&D company focused on aging biology and age-related diseases. Not a grantmaker, but a deep-pocketed private player in the same healthspan mission, competing for the same scientific talent and discoveries.
• National Institute on Aging (NIA / NIH): The largest public funder of aging research in the US, supporting a broad biomedical research portfolio. Hevolution's HF-AGE program specifically funds projects deemed meritorious in NIA peer review but unfunded — making NIA both a complementary and competing capital source.

Others

• XPRIZE Foundation: A nonprofit that runs large incentive competitions to drive breakthrough innovation. Comparable as a prize-based ecosystem builder, and a direct partner through the $101M XPRIZE Healthspan initiative co-founded by Hevolution.

Emerging players

• Buck Institute for Research on Aging: An independent nonprofit biomedical research institute dedicated to aging research. It is a partial peer — a research operator and grant recipient in the same field — and a potential partner or grantee for Hevolution programs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/hevolution_f
• LinkedInlinkedin.com/company/hevolution-f
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hevolution Foundation